Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
17.08
+0.05 (0.29%)
Nov 21, 2024, 4:00 PM EST - Market closed

Teva Pharmaceutical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
19,35211,70310,1298,83510,57610,702
Upgrade
Market Cap Growth
78.61%15.54%14.65%-16.46%-1.18%-36.29%
Upgrade
Enterprise Value
35,62730,33430,27531,94535,84138,076
Upgrade
Last Close Price
17.0810.449.128.019.659.80
Upgrade
PE Ratio
---21.17--
Upgrade
Forward PE
6.504.213.633.023.764.08
Upgrade
PS Ratio
1.150.740.680.560.630.63
Upgrade
PB Ratio
3.191.441.180.790.960.71
Upgrade
P/FCF Ratio
14.1513.909.7237.4416.5847.99
Upgrade
P/OCF Ratio
10.438.556.3711.078.7014.31
Upgrade
PEG Ratio
26.780.401.630.680.540.55
Upgrade
EV/Sales Ratio
2.121.912.032.012.152.25
Upgrade
EV/EBITDA Ratio
7.447.007.637.257.778.58
Upgrade
EV/EBIT Ratio
9.559.5411.3710.3811.7314.02
Upgrade
EV/FCF Ratio
26.0436.0329.05135.3656.18170.75
Upgrade
Debt / Equity Ratio
3.022.492.522.102.401.82
Upgrade
Debt / EBITDA Ratio
3.924.535.265.195.575.95
Upgrade
Debt / FCF Ratio
14.0924.0820.8099.9741.59123.14
Upgrade
Asset Turnover
0.400.360.330.320.310.29
Upgrade
Inventory Turnover
2.102.092.082.022.022.04
Upgrade
Quick Ratio
0.490.540.570.610.510.56
Upgrade
Current Ratio
0.891.021.051.140.990.98
Upgrade
Return on Equity (ROE)
-17.52%-7.35%-25.19%4.09%-31.38%-6.49%
Upgrade
Return on Assets (ROA)
5.56%4.54%3.63%3.91%3.53%2.87%
Upgrade
Return on Capital (ROIC)
8.72%6.77%5.11%5.31%4.77%3.89%
Upgrade
Earnings Yield
-4.96%-4.78%-24.15%4.72%-37.73%-9.33%
Upgrade
FCF Yield
7.07%7.19%10.29%2.67%6.03%2.08%
Upgrade
Buyback Yield / Dilution
-0.87%-0.81%-0.27%-1.10%-0.37%-6.86%
Upgrade
Total Shareholder Return
-0.87%-0.81%-0.27%-1.10%-0.37%-6.86%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.